🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 therapy in patients over 65 — safety and efficacy data Page 7

GLP-1 therapy in patients over 65 — safety and efficacy data

GraceAZ_72 Sun, Apr 5, 2026 at 11:59 AM 40 replies 1,293 viewsPage 7 of 8
kim_atl_prep
Member
312
1,345
Aug 2024
Atlanta, GA
Apr 22, 2026 at 8:11 AM#31
DeniseRN_TPA said:
The mechanism and the magnitude are separate questions.

Coming at DeniseRN_TPA’s question from a different direction. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

49 22PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 46 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Apr 23, 2026 at 12:00 PM#32

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

50 23InsuranceTom, WendyG_ATL, SaraMom3 and 47 others
Reply Quote Save Share Report
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Apr 24, 2026 at 3:50 PM#33

A narrower follow-up, since the general answer is now clear:

How would you tell the difference between that and the alternative explanation?

1 24carlos_SATX
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Apr 25, 2026 at 7:41 PM#34
Dr.PathRoch said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Pushing back on Dr.PathRoch here. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

2 0TomFromTexas, mike.trainer_LA
Reply Quote Save Share Report
KetoKyle
Member
678
3,456
Jul 2024
Utah
Apr 26, 2026 at 11:32 PM#35
Dr.PathRoch said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

3 1JakeBK_lifts, DerekSJ_a1c, paige_pharma
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register